doi:10.1080/09513590.2018.1431769 [47] Ng CM, Blackman MR, Wang C, Swerdloff RS
A manageable component of these costs is site of care for specialty drugs, which are often administered in high-cost hospital settings
Consider these research findings: Biofilm formation: Bacterial biofilms can form in chronic nummular lesions, contributing to treatment resistance [3] Altered drug penetration: The thick, scaly (hyperkeratotic) nature of chronic lesions can reduce the absorption of topical medications [13] Neurogenic inflammation: The density of nerve fibers containing Substance P, a neuropeptide involved in inflammation and itching, is significantly increased in nummular eczema lesions [14] Most frustrating is the rebound phenomenon that can occur after discontinuing topical steroids, which can lead to a dependency cycle [15]
We'll get into that in a second
This application is based on data from the SOUL cardiovascular outcomes trial that demonstrated a 14% relative risk reduction in MACE in patients treated with Rybelsus 14 mg orally once daily for approximately five years compared to those who received placebo
Nat Rev Cancer (2008) 8:42537